Using ultrasound technology to assess muscle health in breast cancer patients
Ultrasound-coupled Electrical Impedance Tomography for Sarcopenia Assessment
This study is testing a new way to check muscle health in breast cancer patients using a combination of ultrasound and electrical signals, making it easier and more accurate to understand how treatment might affect your muscles.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rytek Medical, INC. NIH-funded |
| Lab location | 1 site (Lebanon, United States) |
| Project ID | NIH-10760707 on NIH RePORTER |
What this research studies
This research focuses on developing a new diagnostic tool that combines ultrasound with electrical impedance tomography to better assess muscle health, specifically sarcopenia, in patients undergoing treatment for breast cancer. The goal is to create a more reliable and convenient method for evaluating muscle conditions that can impact treatment outcomes. By improving the accuracy of these assessments, the research aims to tailor therapies to individual patient needs, ultimately enhancing treatment efficacy and minimizing side effects. The approach seeks to overcome the limitations of current diagnostic methods, which can be invasive, expensive, or require significant patient cooperation.
Who could benefit from this research
Good fit: Ideal candidates for this research are breast cancer patients who may be at risk for sarcopenia due to their treatment regimens.
Not a fit: Patients who do not have breast cancer or those who are not undergoing treatment that affects muscle health may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more personalized and effective treatment plans for breast cancer patients by accurately assessing their muscle health.
How similar studies have performed: While the integration of ultrasound with electrical impedance tomography is a novel approach, similar imaging techniques have shown promise in other medical applications.
Where this research is happening
Lebanon, United States
- Rytek Medical, INC. — Lebanon, United States (Active)
Researchers
- Principal investigator: Halter, Ryan Joseph — Rytek Medical, INC.
- Study coordinator: Halter, Ryan Joseph
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.